FDA Inspection 1169174 — JAS Diagnostics, Inc./Drew Scientific, Inc.

JAS Diagnostics, Inc./Drew Scientific, Inc. — FEI 3003071743

The FDA completed an inspection of JAS Diagnostics, Inc./Drew Scientific, Inc. on Apr 28, 2022 in Miami Lakes, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 9 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Apr 28, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
Miami Lakes, FL (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
237121 CFR 820.30(a)Design control - no procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313021 CFR 820.100(a)Lack of or inadequate procedures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.